Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Asthma

Free Subscription Articles published in Respir Med Retrieve available abstracts of 150 articles: HTML format

Single Articles

April 2024
1. CANONICA GW, Domingo C, Lavoie KL, Kaliasethi A, et al
   Asthma patients' and physicians' perspectives on the burden and management of asthma: post-hoc analysis of APPaRENT 1 and 2 to assess predictors of treatment adherence.
   Respir Med. 2024 Apr 16:107637. doi: 10.1016/j.rmed.2024.107637.
   PubMed     Abstract available
   
   
   
2. ROBERTS MH, Duh MS, Rothnie KJ, Zhang S, et al
   Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.
   Respir Med. 2024 Apr 7:107630. doi: 10.1016/j.rmed.2024.107630.
   PubMed     Abstract available
   
   
   
3. SHENG DUH M, Roberts MH, Rothnie KJ, Cheng WY, et al
   Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: a retrospective US claims study.
   Respir Med. 2024 Apr 7:107629. doi: 10.1016/j.rmed.2024.107629.
   PubMed     Abstract available
   
   
   
4. MONDAL P, Lopez SP, Khokhar A, Snyder D, et al
   The influence of body mass index on airway resistance in children with sickle cell disease: A longitudinal study based on impulse oscillometry.
   Respir Med. 2024;224:107564.
   PubMed     Abstract available
   
   
   
5. MAROTT JL, Ingebrigtsen TS, Colak Y, Vestbo J, et al
   Predicting exacerbations in COPD in the Danish general population.
   Respir Med. 2024;224:107557.
   PubMed     Abstract available
   
   
   
6. LAI K, Sun D, Dai R, Samoro R, et al
   Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia.
   Respir Med. 2024 Apr 1:107611. doi: 10.1016/j.rmed.2024.107611.
   PubMed     Abstract available
   
   
   
7. XU X, Yin J, Yang Y, Liu H, et al
   Advances in co-pathogenesis of the united airway diseases.
   Respir Med. 2024;225:107580.
   PubMed     Abstract available
   
   
   March 2024
8. YORGANCIOGLU A, Cruz AA, Garcia G, Lavoie KL, et al
   A network meta-analysis of the association between patient traits and response to regular dosing with ICS plus short-acting beta(2)-agonist reliever or ICS/formoterol reliever only in mild asthma.
   Respir Med. 2024 Mar 30:107610. doi: 10.1016/j.rmed.2024.107610.
   PubMed     Abstract available
   
   
   
9. JEONG J, Nam YH, Sim DW, Kim BK, et al
   Relationship of computed tomography-based measurements with symptom perception and quality of life in patients with severe asthma.
   Respir Med. 2024;225:107598.
   PubMed     Abstract available
   
   
   
10. WIJSMAN PC, Goorsenberg AWM, d'Hooghe JNS, Weersink EJM, et al
    Exhaled breath analyses for bronchial thermoplasty in severe asthma patients.
    Respir Med. 2024 Mar 4:107583. doi: 10.1016/j.rmed.2024.107583.
    PubMed     Abstract available
    
    
    February 2024
11. MANISCALCO M, Candia C, Calabrese C, D'Amato M, et al
    Impact of biologics on lung hyperinflation in patients with severe asthma.
    Respir Med. 2024 Feb 29:107578. doi: 10.1016/j.rmed.2024.107578.
    PubMed     Abstract available
    
    
    
12. ALMQVIST L, Andersson M, Backman H, Ronmark E, et al
    No remission in 60% of those with childhood-onset asthma - A population-based cohort followed from 8 to 28 years of age.
    Respir Med. 2024 Feb 26:107581. doi: 10.1016/j.rmed.2024.107581.
    PubMed     Abstract available
    
    
    
13. FARZANDIPOUR M, Arani MH, Sharif R, Nabovati E, et al
    Improving asthma control and quality of life via a smartphone self-management app: A randomized controlled trial.
    Respir Med. 2024 Feb 5:107539. doi: 10.1016/j.rmed.2024.107539.
    PubMed     Abstract available
    
    
    January 2024
14. ZHANG T, Xu L, Zhang Y, Zhen L, et al
    The diagnostic value of bronchial provocation testing combined with fractional exhaled nitric oxide (FeNO) in children with chest tightness-variant asthma (CTVA).
    Respir Med. 2024 Jan 27:107543. doi: 10.1016/j.rmed.2024.107543.
    PubMed     Abstract available
    
    
    
15. PAPI A, Castro M, Corren J, Pavord ID, et al
    Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma.
    Respir Med. 2024 Jan 23:107535. doi: 10.1016/j.rmed.2024.107535.
    PubMed     Abstract available
    
    
    
16. CHASE NM, Littlejohn M, Holweg CTJ, Millette LA, et al
    Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma.
    Respir Med. 2024 Jan 20:107537. doi: 10.1016/j.rmed.2024.107537.
    PubMed     Abstract available
    
    
    
17. SIORA A, Vontetsianos A, Chynkiamis N, Anagnostopoulou C, et al
    Small airways in asthma: From inflammation and pathophysiology to treatment response.
    Respir Med. 2024 Jan 14:107532. doi: 10.1016/j.rmed.2024.107532.
    PubMed     Abstract available
    
    
    
18. BACKMAN H, Lindmark SW, Hedman L, Kankaanranta H, et al
    The interplay between obesity and blood neutrophils in adult-onset asthma.
    Respir Med. 2024 Jan 10:107529. doi: 10.1016/j.rmed.2024.107529.
    PubMed    
    
    
    
19. BRESLAVSKY A, Al Qaied A, Tsenter P, Mukaseev N, et al
    Comparison of clinical remission criteria for severe asthma patients receiving biologic therapy.
    Respir Med. 2024 Jan 8:107528. doi: 10.1016/j.rmed.2024.107528.
    PubMed     Abstract available
    
    
    
20. DELMAS MC, Pasquereau A, Renuy A, Benezet L, et al
    Electronic cigarette use and respiratory symptoms in the French population-based Constances cohort.
    Respir Med. 2024;221:107496.
    PubMed     Abstract available
    
    
    December 2023
21. VISSER E, Ten Brinke A, Sizoo D, Pepels JJS, et al
    Effect of dietary interventions on markers of type 2 inflammation in asthma: A systematic review.
    Respir Med. 2023;221:107504.
    PubMed     Abstract available
    
    
    
22. DE-MIGUEL-DIEZ J, Gutierrez-Albaladejo N, Caballero-Segura FJ, Lopez-de-Andres A, et al
    Trends and sex differences in atrial fibrillation among patients hospitalized due to asthma: Insights from a nationwide population-based discharge database in Spain, 2016-2021.
    Respir Med. 2023;221:107508.
    PubMed     Abstract available
    
    
    
23. MIR FAKHRAEI R, Lindberg E, Benediktsdottir B, Svanes C, et al
    Gastroesophageal reflux and snoring are related to asthma and respiratory symptoms: Results from a Nordic longitudinal population survey.
    Respir Med. 2023 Dec 13:107495. doi: 10.1016/j.rmed.2023.107495.
    PubMed     Abstract available
    
    
    
24. SUN Y, Zhang Y, Bai W, Liu X, et al
    Relationship between depression severity and respiratory symptoms in US adults: A national cross-sectional study.
    Respir Med. 2023;220:107451.
    PubMed     Abstract available
    
    
    
25. QUADFLIEG K, Machado A, de Lima FF, Dederen A, et al
    Physical status, symptoms and health-related quality of life during a severe exacerbation of COPD: Recovery and discriminative capacity for future events.
    Respir Med. 2023;220:107437.
    PubMed     Abstract available
    
    
    November 2023
26. FREELS L, Herman A, Lukas S, Chan AHY, et al
    Asthma control and associated risk factors among adults with current asthma: Findings from 2019 behavioral risk factor surveillance system asthma call-back survey.
    Respir Med. 2023 Nov 25:107479. doi: 10.1016/j.rmed.2023.107479.
    PubMed     Abstract available
    
    
    
27. ROCHE N, Yorgancioglu A, Cruz AA, Garcia G, et al
    Systematic literature review of traits and outcomes reported in randomised controlled trials of asthma with regular dosing of inhaled corticosteroids with short-acting beta(2)-agonist reliever, as-needed ICS/formoterol, or ICS/formoterol maintenance a
    Respir Med. 2023 Nov 24:107478. doi: 10.1016/j.rmed.2023.107478.
    PubMed     Abstract available
    
    
    
28. MATTILA T, Vasankari T, Herse F, Leskela RL, et al
    Contrasting healthcare costs of COPD and asthma in elderly.
    Respir Med. 2023 Nov 21:107477. doi: 10.1016/j.rmed.2023.107477.
    PubMed     Abstract available
    
    
    
29. URDOVA V, Rogers L, Jesenak M, Seys SF, et al
    Real-life studies and registries of severe asthma: The advent of digital technology.
    Respir Med. 2023 Nov 3:107429. doi: 10.1016/j.rmed.2023.107429.
    PubMed    
    
    
    
30. MATERA MG, Rinaldi B, Ambrosio C, Cazzola M, et al
    Is it preferable to administer a bronchodilator once- or twice-daily when treating COPD?
    Respir Med. 2023;219:107439.
    PubMed     Abstract available
    
    
    October 2023
31. RENNER A, Stoshikj S, Pohl W, Bal C, et al
    Characterization of Austrian severe asthma patients.
    Respir Med. 2023 Oct 10:107427. doi: 10.1016/j.rmed.2023.107427.
    PubMed     Abstract available
    
    
    
32. HENRY C, Biardel S, Boucher M, Godbout K, et al
    Bronchial thermoplasty attenuates bronchodilator responsiveness.
    Respir Med. 2023;217:107340.
    PubMed     Abstract available
    
    
    
33. AXELSSON M, Backman H, Nwaru BI, Stridsman C, et al
    Underdiagnosis and misclassification of COPD in Sweden - A Nordic Epilung study.
    Respir Med. 2023;217:107347.
    PubMed     Abstract available
    
    
    September 2023
34. ROGERS L, Jesenak M, Bjermer L, Hanania NA, et al
    Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.
    Respir Med. 2023 Sep 28:107414. doi: 10.1016/j.rmed.2023.107414.
    PubMed     Abstract available
    
    
    
35. WINSA-LINDMARK S, Stridsman C, Sahlin A, Hedman L, et al
    Severity of adult onset-asthma-a matter of blood neutrophils and severe obesity.
    Respir Med. 2023 Sep 26:107418. doi: 10.1016/j.rmed.2023.107418.
    PubMed     Abstract available
    
    
    
36. KROES JA, Van Hal LHG, Van Dijk L, Zielhuis SW, et al
    The perceived waning of biologics in severe asthma.
    Respir Med. 2023 Sep 25:107416. doi: 10.1016/j.rmed.2023.107416.
    PubMed     Abstract available
    
    
    August 2023
37. MASPERO JF, Shafazand S, Cole J, Pavord ID, et al
    Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma.
    Respir Med. 2023 Aug 31:107344. doi: 10.1016/j.rmed.2023.107344.
    PubMed     Abstract available
    
    
    
38. COTTINI M, Bondi B, Bagnasco D, Braido F, et al
    Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: Prevalence, clinical associations, and impact on asthma control.
    Respir Med. 2023 Aug 16:107391. doi: 10.1016/j.rmed.2023.107391.
    PubMed     Abstract available
    
    
    
39. ASSAF S, Stenberg H, Jesenak M, Tarasevych SP, et al
    Asthma in the era of COVID-19.
    Respir Med. 2023 Aug 9:107373. doi: 10.1016/j.rmed.2023.107373.
    PubMed     Abstract available
    
    
    
40. DIERICK BJH, Achterbosch M, Eikholt AA, Been-Buck S, et al
    Electronic monitoring with a digital smart spacer to support personalized inhaler use education in patients with asthma: The randomized controlled OUTERSPACE trial.
    Respir Med. 2023 Aug 5:107376. doi: 10.1016/j.rmed.2023.107376.
    PubMed     Abstract available
    
    
    
41. KAMINSKY DA, He J, Henderson R, Dixon AE, et al
    Bronchodilator response does not associate with asthma control or symptom burden among patients with poorly controlled asthma.
    Respir Med. 2023 Aug 1:107375. doi: 10.1016/j.rmed.2023.107375.
    PubMed     Abstract available
    
    
    July 2023
42. YORGANCIOGLU A, Cruz AA, Garcia G, Lavoie KL, et al
    A network meta-analysis of the association between patient traits and response to regular dosing with ICS/long-acting beta(2)-agonist plus short-acting beta(2) agonist reliever or maintenance and reliever therapy for asthma.
    Respir Med. 2023 Jul 29:107377. doi: 10.1016/j.rmed.2023.107377.
    PubMed     Abstract available
    
    
    
43. DIAMANT Z, Jesenak M, Hanania NA, Heaney LG, et al
    EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients.
    Respir Med. 2023 Jul 28:107361. doi: 10.1016/j.rmed.2023.107361.
    PubMed    
    
    
    
44. JESENAK M, Durdik P, Oppova D, Franova S, et al
    Dysfunctional mucociliary clearance in asthma and airway remodeling - New insights into an old topic.
    Respir Med. 2023 Jul 27:107372. doi: 10.1016/j.rmed.2023.107372.
    PubMed     Abstract available
    
    
    
45. CHAN AHY, Tomlin A, Beyene K, Harrison J, et al
    Asthma exacerbations in New Zealand 2010-2019: A national population-based study.
    Respir Med. 2023;217:107365.
    PubMed     Abstract available
    
    
    
46. PONTE EV, Rocha DGD, Guinossi RM, Bertoche L, et al
    Evaluating the relationship between the type of rescue medication and the adequacy of asthma maintenance therapy.
    Respir Med. 2023 Jul 18:107364. doi: 10.1016/j.rmed.2023.107364.
    PubMed     Abstract available
    
    
    
47. DIAMANT Z, Seys SF, Rogers L, Hanania NA, et al
    Integrating innovations in asthma research into clinical practice.
    Respir Med. 2023;217:107345.
    PubMed    
    
    
    
48. BAYDUR A, Barbers R, May D
    Effect of bronchial thermoplasty on static and dynamic lung compliance and resistance in patients with severe persistent asthma.
    Respir Med. 2023 Jul 8:107341. doi: 10.1016/j.rmed.2023.107341.
    PubMed     Abstract available
    
    
    
49. GEPHINE S, Fry S, Margoline E, Gicquello A, et al
    Home-based pulmonary rehabilitation for adults with severe asthma exposed to psychosocial chronic stressors.
    Respir Med. 2023 Jul 7:107349. doi: 10.1016/j.rmed.2023.107349.
    PubMed     Abstract available
    
    
    
50. PORTACCI A, Iorillo I, Quaranta VN, Maselli L, et al
    Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience.
    Respir Med. 2023;217:107348.
    PubMed     Abstract available
    
    
    June 2023
51. KOSTIKAS K, Maspero JF, Chapman KR, Mezzi K, et al
    Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM study.
    Respir Med. 2023 Jun 29:107334. doi: 10.1016/j.rmed.2023.107334.
    PubMed     Abstract available
    
    
    
52. MOHAN A, Lugogo NL
    Mild asthma: Lessons learned and remaining questions.
    Respir Med. 2023 Jun 14:107326. doi: 10.1016/j.rmed.2023.107326.
    PubMed     Abstract available
    
    
    
53. ADRISH M, Akuthota P
    Approach to non-type 2 asthma.
    Respir Med. 2023 Jun 10:107327. doi: 10.1016/j.rmed.2023.107327.
    PubMed    
    
    
    
54. NISHIYAMA H, Kanemitsu Y, Hara J, Fukumitsu K, et al
    Bronchial thermoplasty improves cough hypersensitivity and cough in severe asthmatics.
    Respir Med. 2023 Jun 10:107303. doi: 10.1016/j.rmed.2023.107303.
    PubMed     Abstract available
    
    
    
55. PANETTIERI RA, Lugogo N, Moore WC, Chipps BE, et al
    Real-world effectiveness of benralizumab in US subspecialist-treated adults with severe asthma: Findings from CHRONICLE.
    Respir Med. 2023 Jun 6:107285. doi: 10.1016/j.rmed.2023.107285.
    PubMed     Abstract available
    
    
    
56. STURESSON A, Hedman L, Stridsman C, Lindberg A, et al
    Obesity associates with increased all-cause and cardiovascular mortality in adults with asthma.
    Respir Med. 2023 Jun 4:107301. doi: 10.1016/j.rmed.2023.107301.
    PubMed     Abstract available
    
    
    
57. SELBERG S, Karlsson Sundbaum J, Konradsen JR, Backman H, et al
    Multiple manifestations of uncontrolled asthma increase the risk of severe COVID-19.
    Respir Med. 2023;216:107308.
    PubMed     Abstract available
    
    
    
58. KISIEL MA, Sedvall M, Malinovschi A, Franklin KA, et al
    Inflammatory bowel disease and asthma. Results from the RHINE study.
    Respir Med. 2023 Jun 2:107307. doi: 10.1016/j.rmed.2023.107307.
    PubMed     Abstract available
    
    
    
59. ESTEBAN C, Anton-Ladislao A, Aramburu A, Chasco L, et al
    Change in physical activity related to admission for exacerbation in COPD patients.
    Respir Med. 2023;212:107236.
    PubMed     Abstract available
    
    
    May 2023
60. BRUNN B, Hapfelmeier A, Jorres RA, Schultz K, et al
    Development of a diagnostic score using FeNO and symptoms to predict asthma.
    Respir Med. 2023 May 29:107299. doi: 10.1016/j.rmed.2023.107299.
    PubMed     Abstract available
    
    
    
61. LIANG Y, Zhang J, Bai S, Du S, et al
    Short-term and long-term effects of cesarean section on asthma and wheezing: A cohort study and meta-analysis.
    Respir Med. 2023 May 29:107300. doi: 10.1016/j.rmed.2023.107300.
    PubMed     Abstract available
    
    
    
62. FONG KY, Zhao JJ, Syn NL, Nair P, et al
    Comparing bronchial thermoplasty with biologicals for severe asthma: Systematic review and network meta-analysis.
    Respir Med. 2023 May 29:107302. doi: 10.1016/j.rmed.2023.107302.
    PubMed     Abstract available
    
    
    
63. LOZANO-ESPINOSA M, Antolin-Amerigo D, Riera J, Gordo Vidal F, et al
    Extracorporeal membrane oxygenation (ECMO) and beyond in near fatal asthma: A comprehensive review.
    Respir Med. 2023;215:107246.
    PubMed     Abstract available
    
    
    
64. KHAN S, Ouaalaya EH, Chauveau AD, Scherer E, et al
    Whispers of change in preschool asthma phenotypes: Findings in the French ELFE cohort.
    Respir Med. 2023 May 22:107263. doi: 10.1016/j.rmed.2023.107263.
    PubMed     Abstract available
    
    
    
65. BOUSSO A, Chuffart C, Leroy M, Gicquello A, et al
    Severity and phenotypes of dyspnea in asthma: Impact of comorbidities.
    Respir Med. 2023 May 20:107276. doi: 10.1016/j.rmed.2023.107276.
    PubMed     Abstract available
    
    
    
66. KHORASANI AM, Mohammadi B, Saghafi MR, Mohammadi S, et al
    The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.
    Respir Med. 2023 May 3:107260. doi: 10.1016/j.rmed.2023.107260.
    PubMed     Abstract available
    
    
    
67. LAORDEN D, Zamarron E, Romero D, Dominguez-Ortega J, et al
    Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R.
    Respir Med. 2023;211:107216.
    PubMed    
    
    
    
68. BASHIR MBA, Basna R, Hedman L, Backman H, et al
    Interaction of smoking and social status on the risk of respiratory outcomes in a Swedish adult population: A Nordic Epilung study.
    Respir Med. 2023;211:107192.
    PubMed     Abstract available
    
    
    April 2023
69. PRICE OJ, Simpson AJ
    Exercise and asthma - trigger or treatment?
    Respir Med. 2023;213:107247.
    PubMed     Abstract available
    
    
    
70. GU W, Tian Z, Tian W, Song Y, et al
    Association of rest-activity circadian rhythm with chronic respiratory diseases, a cross-section survey from NHANES 2011-2014.
    Respir Med. 2023;209:107147.
    PubMed     Abstract available
    
    
    March 2023
71. KISIEL MA, Arnfelt O, Lindberg E, Jogi O, et al
    Association between abdominal and general obesity and respiratory symptoms, asthma and COPD. Results from the RHINE study.
    Respir Med. 2023;211:107213.
    PubMed     Abstract available
    
    
    
72. VAN DER BURG N, Tufvesson E
    Is asthma's heterogeneity too vast to use traditional phenotyping for modern biologic therapies?
    Respir Med. 2023 Mar 14:107211. doi: 10.1016/j.rmed.2023.107211.
    PubMed    
    
    
    
73. VAN ZYL-SMIT RN, Kerstjens HA, Maspero JF, Kostikas K, et al
    Efficacy of once-daily, single-inhaler, fixed-dose combination of mometasone/indacaterol/glycopyrronium in patients with asthma with or without persistent airflow limitation: Post hoc analysis from the IRIDIUM study.
    Respir Med. 2023 Mar 9:107172. doi: 10.1016/j.rmed.2023.107172.
    PubMed     Abstract available
    
    
    February 2023
74. BAKAKOS P, Tryfon S, Palamidas A, Mathioudakis N, et al
    Patient characteristics and eligibility for biologics in severe asthma: Results from the Greek cohort of the RECOGNISE "real world" study.
    Respir Med. 2023;210:107170.
    PubMed     Abstract available
    
    
    
75. ERJEFALT JS
    Anatomical and histopathological approaches to asthma phenotyping.
    Respir Med. 2023 Feb 21:107168. doi: 10.1016/j.rmed.2023.107168.
    PubMed     Abstract available
    
    
    
76. COTTINI M, Lombardi C, Comberiati P, Landi M, et al
    Small airway dysfunction in asthmatic patients treated with as-needed SABA monotherapy: A perfect storm.
    Respir Med. 2023 Feb 14:107154. doi: 10.1016/j.rmed.2023.107154.
    PubMed     Abstract available
    
    
    
77. SORENSEN KG, Oymar K, Jonsson G, Dalen I, et al
    Are BMI and adipokines associated with asthma, atopy and lung function in young adults previously hospitalized for bronchiolitis?
    Respir Med. 2023 Feb 6:107149. doi: 10.1016/j.rmed.2023.107149.
    PubMed     Abstract available
    
    
    
78. DESORMEAU B, Smyrnova A, Drouin O, Ducharme FM, et al
    Oscillometry to support clinical assessment in asthmatic preschoolers: Real-life impact.
    Respir Med. 2023 Feb 6:107148. doi: 10.1016/j.rmed.2023.107148.
    PubMed     Abstract available
    
    
    
79. HILVERING B, Koenderman L
    Quality over quantity; eosinophil activation status will deepen the insight into eosinophilic diseases.
    Respir Med. 2023;207:107094.
    PubMed     Abstract available
    
    
    January 2023
80. DIAMANT Z, van Maaren M, Muraro A, Jesenak M, et al
    Allergen immunotherapy for allergic asthma - The future seems bright.
    Respir Med. 2023 Jan 23:107125. doi: 10.1016/j.rmed.2023.107125.
    PubMed    
    
    
    
81. POMPE E, Kwee AK, Tejwani V, Siddharthan T, et al
    Imaging-derived biomarkers in Asthma: Current status and future perspectives.
    Respir Med. 2023 Jan 23:107130. doi: 10.1016/j.rmed.2023.107130.
    PubMed     Abstract available
    
    
    
82. AL-SHUWELI S, Landt E, Ellervik C, Poulsen HE, et al
    Risk of asthma in offspring of asthmatic fathers versus mothers: A population-based study of 21,000 individuals in Denmark.
    Respir Med. 2023;207:107116.
    PubMed     Abstract available
    
    
    
83. MACNEIL A, Li G, Jiang Y, de Groh M, et al
    Incident and recurrent depression among older adults with asthma during the COVID-19 pandemic: Findings from the Canadian Longitudinal Study on Aging.
    Respir Med. 2023 Jan 11:107003. doi: 10.1016/j.rmed.2022.107003.
    PubMed     Abstract available
    
    
    
84. LOSOL P, Sokolowska M, Chang YS
    Interactions between microbiome and underlying mechanisms in asthma.
    Respir Med. 2023 Jan 11:107118. doi: 10.1016/j.rmed.2023.107118.
    PubMed     Abstract available
    
    
    
85. LIU Y, Li P, Jiang T, Li Y, et al
    Epidermal growth factor receptor in asthma: A promising therapeutic target?
    Respir Med. 2023;207:107117.
    PubMed     Abstract available
    
    
    December 2022
86. MATTILA T, Vasankari T, Kauppi P, Mazur W, et al
    Mortality of asthma, COPD, and asthma-COPD overlap during an 18-year follow up.
    Respir Med. 2022 Dec 31:107112. doi: 10.1016/j.rmed.2022.107112.
    PubMed     Abstract available
    
    
    
87. THEODORO EE, Rocha DGD, Bertolino JR, Guinossi RM, et al
    Evaluating the effect of antidepressants on the relationship between depression and asthma.
    Respir Med. 2022;207:107099.
    PubMed     Abstract available
    
    
    
88. LOUIS G, Schleich F, Louis R, Guillaume M, et al
    How respiratory symptoms impact asthma-related quality of life in mild asthmatics.
    Respir Med. 2022;207:107098.
    PubMed     Abstract available
    
    
    
89. RENNER A, Marth K, Breyer-Kohansal R, Pohl W, et al
    Combined analysis of five non-interventional studies of the effectiveness, tolerability, and safety of the extrafine fixed dose beclomethasone/formoterol combination in the treatment of asthma in Austria.
    Respir Med. 2022;207:107097.
    PubMed     Abstract available
    
    
    
90. LI J, Price KR, Weeda ER, Garner SS, et al
    Trends in prescribing as-needed inhaled corticosteroid (ICS)-Formoterol for patients with asthma.
    Respir Med. 2022;207:107096.
    PubMed    
    
    
    
91. LAORDEN D, Dominguez-Ortega J, Carpio C, Barranco P, et al
    Long COVID outcomes in an asthmatic cohort and its implications for asthma control.
    Respir Med. 2022 Dec 16:107092. doi: 10.1016/j.rmed.2022.107092.
    PubMed    
    
    
    
92. GOUDARZI H, Kimura H, Kimura H, Makita H, et al
    Association of serum CC16 levels with eosinophilic inflammation and respiratory dysfunction in severe asthma.
    Respir Med. 2022;206:107089.
    PubMed     Abstract available
    
    
    
93. ROTHE T, von Garnier C, Bridevaux PO, Charbonnier F, et al
    The clinical features of asthma exacerbations in early-onset and eosinophilic late-onset asthma may differ significantly.
    Respir Med. 2022;206:107067.
    PubMed     Abstract available
    
    
    November 2022
94. THELEN JC, van Zelst CM, van Brummelen SE, Rauh S, et al
    Efficacy and safety of dupilumab as add-on therapy for patients with severe asthma: A real-world Dutch cohort study.
    Respir Med. 2022;206:107058.
    PubMed     Abstract available
    
    
    
95. ROCHE N, Nadif R, Fabry-Vendrand C, Pillot L, et al
    Asthma burden according to treatment steps in the French population-based cohort CONSTANCES.
    Respir Med. 2022;206:107057.
    PubMed     Abstract available
    
    
    
96. PLEASANTS RA, Chan AH, Mosnaim G, Costello RW, et al
    Integrating digital inhalers into clinical care of patients with asthma and chronic obstructive pulmonary disease.
    Respir Med. 2022;205:107038.
    PubMed     Abstract available
    
    
    
97. SANSORES RH, Paulin-Prado P, Robles-Hernandez R, Montiel-Lopez F, et al
    Clinical and microbiological characteristics and inflammatory profile during an exacerbation of COPD due to biomass exposure. A comparison with COPD due to tobacco exposure.
    Respir Med. 2022;204:107010.
    PubMed     Abstract available
    
    
    October 2022
98. MAIO S, Murgia N, Tagliaferro S, Angino A, et al
    The Italian severe/uncontrolled asthma registry (RItA): A 12-month clinical follow-up.
    Respir Med. 2022;205:107030.
    PubMed     Abstract available
    
    
    
99. VAN DER PALEN J, Slade D, Rehal S, Verma M, et al
    A randomized, cross-over study comparing critical and overall errors, learning time, and preference of the ELLIPTA versus BREEZHALER dry powder inhalers in patients with asthma.
    Respir Med. 2022;205:107031.
    PubMed     Abstract available
    
    
    
100. RYAN D, Keighley A, Jackson T
     Patient perspectives in asthma: Listening to and learning from a new paradigm in translational research.
     Respir Med. 2022;205:107013.
     PubMed    
     
     
     
101. CHAN KC, Au CT, Wong E, Chook P, et al
     Inferior endothelial function improved following optimisation of asthma control in children.
     Respir Med. 2022;204:107024.
     PubMed     Abstract available
     
     
     
102. TOOBA R, Wu TD
     Obesity and asthma: A focused review.
     Respir Med. 2022;204:107012.
     PubMed    
     
     
     
103. CABALLERO-SEGURA FJ, Lopez-de-Andres A, Jimenez-Garcia R, de Miguel-Yanes JM, et al
     Trends in asthma hospitalizations among adults in Spain: Analysis of hospital discharge data from 2011 to 2020.
     Respir Med. 2022;204:107009.
     PubMed     Abstract available
     
     
     
104. GHOSH S, Rihan M, Ahmed S, Pande AH, et al
     Immunomodulatory potential of apolipoproteins and their mimetic peptides in asthma: Current perspective.
     Respir Med. 2022;204:107007.
     PubMed     Abstract available
     
     
     September 2022
105. MANEECHOTESUWAN K, Singh D, Fritscher LG, Dursunoglu N, et al
     Impact of inhaled fluticasone propionate/salmeterol on health-related quality of life in asthma: A network meta-analysis.
     Respir Med. 2022;203:106993.
     PubMed     Abstract available
     
     
     
106. TRAN C, Singh GV, Haider E, Boylan C, et al
     Luminal mucus plugs are spatially associated with airway wall thickening in severe COPD and asthma: A single-centered, retrospective, observational study.
     Respir Med. 2022;202:106982.
     PubMed     Abstract available
     
     
     
107. ROCHE N, Aggarwal B, Boucot I, Mittal L, et al
     The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: A systematic review.
     Respir Med. 2022;202:106949.
     PubMed     Abstract available
     
     
     August 2022
108. BOURDIN A, Virchow JC, Papi A, Lugogo NL, et al
     Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline.
     Respir Med. 2022;202:106938.
     PubMed     Abstract available
     
     
     
109. TAJIRI S, Kondo T, Tanigaki T, Hibino M, et al
     Daily inhaled flow profiles and drug release from dry powder inhalers in patients with bronchial asthma.
     Respir Med. 2022;201:106950.
     PubMed     Abstract available
     
     
     
110. CHAPMAN KR, Canonica GW, Lavoie KL, Nenasheva N, et al
     Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study.
     Respir Med. 2022;201:106948.
     PubMed     Abstract available
     
     
     
111. CANONICA GW, Spanevello A, de Llano LP, Domingo Ribas C, et al
     Is asthma control more than just an absence of symptoms? An expert consensus statement.
     Respir Med. 2022;202:106942.
     PubMed     Abstract available
     
     
     
112. TRELA KC, Zajac P, Zhu M, Press VG, et al
     Health literacy and type of education intervention predicting post-education metered-dose inhaler misuse.
     Respir Med. 2022;200:106930.
     PubMed     Abstract available
     
     
     July 2022
113. ORLOVIC M, Magni T, Lukyanov V, Guerra I, et al
     Cost-effectiveness of single-inhaler extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium in patients with uncontrolled asthma in England.
     Respir Med. 2022;201:106934.
     PubMed     Abstract available
     
     
     
114. LI M, Wen Ma Z, Jun Deng S, Oliver BG, et al
     Development and validation of a noninvasive prediction model for identifying eosinophilic asthma.
     Respir Med. 2022;201:106935.
     PubMed     Abstract available
     
     
     
115. HENRY SL, Moore LE, Brotto AR, Rowland S, et al
     Systemic vascular health is compromised in both confirmed and unconfirmed asthma.
     Respir Med. 2022;200:106932.
     PubMed     Abstract available
     
     
     
116. ALHABEEB FF, Whitmore GA, Vandemheen KL, FitzGerald JM, et al
     Disease burden in individuals with symptomatic undiagnosed asthma or COPD.
     Respir Med. 2022;200:106917.
     PubMed     Abstract available
     
     
     June 2022
117. PATELLA V, Pelaia C, Zunno R, Pelaia G, et al
     Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic.
     Respir Med. 2022;200:106916.
     PubMed     Abstract available
     
     
     
118. LIU L, Zhang X, Zhang L, Liu Y, et al
     Reduced bronchodilator reversibility correlates with non-type 2 high asthma and future exacerbations: A prospective cohort study.
     Respir Med. 2022;200:106924.
     PubMed     Abstract available
     
     
     
119. HUGHES R, Rapsomaniki E, Janson C, Keen C, et al
     Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study.
     Respir Med. 2022;200:106921.
     PubMed     Abstract available
     
     
     
120. CAZZOLA M, Braido F, Calzetta L, Matera MG, et al
     The 5T approach in asthma: Triple Therapy Targeting Treatable Traits.
     Respir Med. 2022;200:106915.
     PubMed     Abstract available
     
     
     
121. LEONARD SI, Turi ER, Powell JS, Usseglio J, et al
     Associations of asthma self-management and mental health in adolescents: A scoping review.
     Respir Med. 2022;200:106897.
     PubMed     Abstract available
     
     
     May 2022
122. SON JH, Park JS, Lee JU, Kim MK, et al
     A genome-wide association study on frequent exacerbation of asthma depending on smoking status.
     Respir Med. 2022 May 17:106877. doi: 10.1016/j.rmed.2022.106877.
     PubMed     Abstract available
     
     
     
123. IKWU I, Nicolas LG, Mehari A, Gillum RF, et al
     Fractional exhaled nitric oxide and mortality in asthma and chronic obstructive pulmonary disease in a national cohort aged 40 years and older.
     Respir Med. 2022 May 16:106879. doi: 10.1016/j.rmed.2022.106879.
     PubMed     Abstract available
     
     
     
124. JIAO T, Schnitzer ME, Forget A, Blais L, et al
     Identifying asthma patients at high risk of exacerbation in a routine visit: A machine learning model.
     Respir Med. 2022;198:106866.
     PubMed     Abstract available
     
     
     
125. GOLAM SM, Janson C, Beasley R, FitzGerald JM, et al
     The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study.
     Respir Med. 2022;200:106863.
     PubMed     Abstract available
     
     
     March 2022
126. KORN S, Milger K, Skowasch D, Timmermann H, et al
     Corrigendum to "The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control" [Respir. Med. 195 (2022) 106793].
     Respir Med. 2022;196:106827.
     PubMed    
     
     
     February 2022
127. KORN S, Milger K, Skowasch D, Timmermann H, et al
     The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control.
     Respir Med. 2022;195:106793.
     PubMed     Abstract available
     
     
     
128. BENDIEN SA, van Leeuwen MM, Lau HS, Ten Brinke A, et al
     Home-based intravenous treatment with reslizumab for severe asthma in the Netherlands - An evaluation.
     Respir Med. 2022 Feb 23:106776. doi: 10.1016/j.rmed.2022.106776.
     PubMed     Abstract available
     
     
     
129. AL-AHMAD M, Webb D
     A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (
     Respir Med. 2022;194:106771.
     PubMed     Abstract available
     
     
     January 2022
130. JI Z, Lopez-de-Andres A, Jimenez-Garcia R, Maestre-Miquel C, et al
     Mental health in patients with asthma: A population-based case-control study.
     Respir Med. 2022;193:106758.
     PubMed     Abstract available
     
     
     
131. VRSALOVIC R, Korosec P, Stefanovic IM, Bidovec-Stojkovic U, et al
     Value of thymic stromal lymphopoietin as a biomarker in children with asthma.
     Respir Med. 2022;193:106757.
     PubMed     Abstract available
     
     
     
132. BOURDIN A, Molinari N
     Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma.
     Respir Med. 2022;191:105999.
     PubMed    
     
     
     
133. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
     Response to the correspondence: "Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma".
     Respir Med. 2022;191:106088.
     PubMed    
     
     
     
134. MARTIN N, Papi A, Bratton DJ, Chan R, et al
     Comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020].
     Respir Med. 2022;191:106065.
     PubMed    
     
     
     
135. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
     Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma.
     Respir Med. 2022;191:105991.
     PubMed     Abstract available
     
     
     
136. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
     Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020).
     Respir Med. 2022;191:106106.
     PubMed    
     
     
     December 2021
137. MONTEIRO C, Maricoto T, Prazeres F, Augusto Simoes P, et al
     Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature.
     Respir Med. 2021;191:106724.
     PubMed     Abstract available
     
     
     
138. PENG J, Wu F, Tian H, Yang H, et al
     Clinical characteristics of and risk factors for small airway dysfunction detected by impulse oscillometry.
     Respir Med. 2021;190:106681.
     PubMed     Abstract available
     
     
     November 2021
139. FAN Q, Ong ASE, Koh MS, Doshi K, et al
     The mediating role of trust in physician and self-efficacy in understanding medication adherence in severe asthma.
     Respir Med. 2021;190:106673.
     PubMed     Abstract available
     
     
     
140. ZAIGHAM S, Zhou X, Molin M, Sjolander A, et al
     Importance of type and degree of IgE sensitisation for defining fractional exhaled nitric oxide reference values.
     Respir Med. 2021;188:106621.
     PubMed     Abstract available
     
     
     October 2021
141. CZIRA A, Turner M, Martin A, Hinds D, et al
     A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma.
     Respir Med. 2021;191:106670.
     PubMed     Abstract available
     
     
     
142. ROGLIANI P, Ritondo BL, Puxeddu E, Cazzola M, et al
     Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review.
     Respir Med. 2021;189:106639.
     PubMed     Abstract available
     
     
     
143. RODRIGUEZ-GARCIA C, Blanco-Aparicio M, Nieto-Fontarigo JJ, Blanco-Cid N, et al
     Efficacy of mepolizumab in usual clinical practice and characteristics of responders.
     Respir Med. 2021;187:106595.
     PubMed     Abstract available
     
     
     
144. AGUSTI A, Barnes N, Cruz AA, Gibson PG, et al
     Moving towards a Treatable Traits model of care for the management of obstructive airways diseases.
     Respir Med. 2021;187:106572.
     PubMed     Abstract available
     
     
     
145. RIIKONEN R, Korppi M, Tormanen S, Koponen P, et al
     Risk factors for irreversible airway obstruction after infant bronchiolitis.
     Respir Med. 2021;187:106545.
     PubMed     Abstract available
     
     
     June 2021
146. AL-QEREM WA, Jarab AS
     Applicability of GLI 2012 spirometry equation among preschool aged Jordanian.
     Respir Med. 2021;182:106397.
     PubMed     Abstract available
     
     
     May 2021
147. CORDOVA-RIVERA L, Gardiner PA, Gibson PG, Winkler EAH, et al
     Sedentary time in people with obstructive airway diseases.
     Respir Med. 2021;181:106367.
     PubMed     Abstract available
     
     
     April 2021
148. TIOTIU A, Ioan I, Poussel M, Schweitzer C, et al
     Comparative analysis between available challenge tests in the hyperventilation syndrome.
     Respir Med. 2021;179:106329.
     PubMed     Abstract available
     
     
     January 2021
149. ZELL-BARAN LM, Krefft SD, Moore CM, Wolff J, et al
     Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers.
     Respir Med. 2021;176:106281.
     PubMed     Abstract available
     
     
     
150. BJERRUM AS, Skjold T, Schmid JM
     Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatment.
     Respir Med. 2021;176:106260.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.